In this article published in The Pink Sheet, Tim Wilsdon and Ryan Lawlor explore the relationship between various procurement models and vaccine coverage rates in Europe. They discuss how certain procurement methods help contribute to a sustainable “vaccine ecosystem.”
To read the article, click here.
Note: subscription required to access
Consequences of counterfeit pharmaceutical product sales
Recently, both the FDA and EMA have raised concerns about counterfeit drug products, including GLP-1s used for weight loss and diabetes, being marketed in the...